Chinese Official Says Baxter Failed To Cooperate In Heparin Probe
This article was originally published in PharmAsia News
China's chief drug researcher accused Baxter International of failing to cooperate in an investigation of the source of China-made heparin. Jin Shaohong, deputy director of the China National Institute for the Control of Pharmaceutical and Biological Products, said Baxter would not supply test samples of its drug. Jin also said he does not believe the 81 U.S. deaths attributed to heparin were linked directly to the hypersulfated chondroitin sulfate made in China. U.S. officials say they have traced the problem heparin to Kaipu, a company in China. Jin noted two other users of Kaipu heparin experienced no ill effects. (Click here for more
You may also be interested in...
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.
The US Medicare agency is offering more lower-cost alternative sites for 2021 surgical procedures to be covered under its OPPS and ASC final rule.